9.7363
price up icon2.23%   0.2063
 
loading

10 X Genomics Inc Stock (TXG) Forecast

The 10 X Genomics Inc (TXG) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $112.62, representing a +1,057% increase from the current price of $9.7363. The highest analyst price target is $132.52, and the lowest is $92.72.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TXG Price Target
Average 140.51 (+1,343% Upside)
loading

Is 10 X Genomics Inc (TXG) A Buy Now?

Oscillators
Name Value Action
RSI(14) 60.26 Neutral
STOCH(9,6) 64.10 Neutral
STOCHRSI(14) 90.49 Sell
MACD(12,26) 0.155 Buy
ADX(14) 15.29 Neutral
William %R -2.3188 Sell
CCI(14) 100.41 Buy
Buy: 2 Sell: 2 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
8.9105
Buy
9.0996
Buy
MA20
8.9188
Buy
8.9256
Buy
MA50
8.6349
Buy
9.2117
Buy
MA100
10.75
Sell
10.74
Sell
MA200
14.34
Sell
14.88
Sell
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, TXG could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 6 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on TXG, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 60.26 indicates that TXG is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 64.1 indicates that TXG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 90.49 indicates that TXG is oversold. This suggests that TXG price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 15.29 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 100.41 indicates that TXG is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term TXG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about 10 X Genomics Inc financial reports and earnings history, 10 X Genomics Inc (TXG) stock could reach $59.72 by 2030, $2.1118 by 2040 and $32.21 by 2050. See the projected annual prices until 2050 of the 10 X Genomics Inc stock below:

  • 10 X Genomics Inc (TXG) is expected to reach an average price of $18.99 in 2035, with a high prediction of $21.02 and a low estimate of $17.89. This indicates an $95.03% rise from the last recorded price of $9.7363.
  • 10 X Genomics Inc (TXG) stock is projected to chart a bullish course in 2040, with an average price target of $5.2877, representing an $-45.69% surge from its current level. The forecast ranges from a conservative $4.6918 to a sky-high $2.1118.
  • Our analysts predict 10 X Genomics Inc (TXG) to jump 41.95% by 2045, soaring from $0.597 to an average price of $13.82, potentially reaching $9.6205. While $0.597 is the low estimate, the potential upside is significant.
  • 10 X Genomics Inc (TXG) stock is expected to climb by 2050, reaching an average of $36.25, a $272.27% jump from its current level. However, a wide range of estimates exists, with high and low targets of $32.21 and $35.02, respectively, highlighting the market's uncertainty.

10 X Genomics Inc Stock (TXG) Year by Year Forecast

10 X Genomics Inc Stock (TXG) Price Forecast for 2025

10 X Genomics Inc Stock (TXG) is expected to reach an average price of $107.19 in 2025, with a high prediction of $180.11 and a low estimate of $34.28. This indicates an +1,001% rise from the last recorded price of $9.7363.
Month Average Low High Change from today's price
July, 2025 $132.00 $92.72 $132.52 +1,256%
August, 2025 $125.39 $112.32 $143.91 +1,188%
September, 2025 $131.05 $103.57 $135.35 +1,246%
October, 2025 $119.59 $118.81 $140.77 +1,128%
November, 2025 $149.42 $115.91 $169.47 +1,435%
December, 2025 $134.07 $119.34 $180.11 +1,277%

10 X Genomics Inc Stock (TXG) Price Forecast for 2026

The predicted value for 10 X Genomics Inc (TXG) in 2026 is set at an average of $125.32. Estimates vary from a peak of $188.29 to a trough of $62.36, indicating an +1,187% surge from the present price of $9.7363.
Month Average Low High Change from today's price
January, 2026 $159.67 $119.10 $161.86 +1,540%
February, 2026 $172.80 $155.24 $182.01 +1,675%
March, 2026 $137.20 $107.14 $182.15 +1,309%
April, 2026 $168.98 $138.22 $182.85 +1,636%
May, 2026 $150.61 $145.43 $188.29 +1,447%
June, 2026 $139.89 $136.06 $170.35 +1,337%
July, 2026 $164.34 $132.96 $170.99 +1,588%
August, 2026 $123.49 $121.43 $164.56 +1,168%
September, 2026 $158.22 $117.43 $168.09 +1,525%
October, 2026 $133.23 $120.19 $160.17 +1,268%
November, 2026 $126.69 $109.51 $138.20 +1,201%
December, 2026 $68.22 $62.36 $134.74 +600.67%

10 X Genomics Inc Stock (TXG) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for 10 X Genomics Inc (TXG) is $43.78, with a high forecast of $80.91 and a low forecast of $6.6413. This indicates an +349.61% increase from the last price of $9.7363.
Month Average Low High Change from today's price
January, 2027 $62.56 $56.87 $80.91 +542.53%
February, 2027 $42.85 $42.59 $65.12 +340.08%
March, 2027 $52.90 $35.94 $64.74 +443.33%
April, 2027 $32.77 $26.90 $58.90 +236.57%
May, 2027 $32.95 $18.38 $35.52 +238.41%
June, 2027 $27.23 $17.04 $33.48 +179.69%
July, 2027 $17.27 $15.42 $35.38 +77.38%
August, 2027 $18.68 $16.47 $36.06 +91.85%
September, 2027 $13.24 $12.64 $21.51 +36.02%
October, 2027 $8.3219 $7.5669 $15.40 -14.53%
November, 2027 $14.83 $6.6413 $15.89 +52.32%
December, 2027 $22.11 $13.16 $24.93 +127.13%

10 X Genomics Inc Stock (TXG) Price Forecast for 2028

In 2028, 10 X Genomics Inc (TXG) is projected to reach an average price of $31.51, with a high projection of $48.41 and a low estimate of $14.60. This indicates an +223.61% rise from the last price of $9.7363.
Month Average Low High Change from today's price
January, 2028 $19.76 $14.60 $22.10 +102.98%
February, 2028 $32.15 $18.15 $32.96 +230.23%
March, 2028 $30.79 $25.63 $36.68 +216.19%
April, 2028 $32.03 $27.11 $35.20 +229.02%
May, 2028 $37.84 $30.80 $40.21 +288.63%
June, 2028 $39.66 $34.39 $40.48 +307.31%
July, 2028 $38.45 $35.20 $42.65 +294.87%
August, 2028 $42.81 $36.67 $44.71 +339.68%
September, 2028 $40.93 $39.74 $48.41 +320.36%
October, 2028 $36.92 $29.87 $41.97 +279.16%
November, 2028 $26.54 $25.47 $39.98 +172.59%
December, 2028 $21.88 $21.77 $28.06 +124.72%

10 X Genomics Inc Stock (TXG) Price Forecast for 2029

The 2029 price forecast for 10 X Genomics Inc Stock (TXG) is $22.50 on average, with a high prediction of $43.82 and a low estimate of $1.1818. This represents an +131.08% increase from the previous price of $9.7363.
Month Average Low High Change from today's price
January, 2029 $29.05 $19.35 $29.96 +198.39%
February, 2029 $39.34 $26.97 $41.64 +304.07%
March, 2029 $33.04 $32.00 $43.82 +239.35%
April, 2029 $29.83 $26.61 $32.09 +206.37%
May, 2029 $32.01 $28.95 $37.54 +228.80%
June, 2029 $24.16 $22.01 $32.10 +148.16%
July, 2029 $14.40 $13.11 $24.54 +47.90%
August, 2029 $0.5088 $1.3994 $16.22 -94.77%
September, 2029 $2.3365 $1.1818 $4.0665 -76.00%
October, 2029 $18.13 $1.3491 $18.47 +86.25%
November, 2029 $11.61 $10.60 $18.74 +19.26%
December, 2029 $26.56 $7.2006 $39.80 +172.78%

10 X Genomics Inc Stock (TXG) Price Forecast for 2030

10 X Genomics Inc Stock (TXG) is expected to reach an average price of $61.18 in 2030, with a high forecast of $121.51 and a low forecast of $0.8518. This signifies an +528.39% surge from the last price of $9.7363.
Month Average Low High Change from today's price
January, 2030 $40.43 $23.83 $59.72 +315.21%
February, 2030 $23.08 $13.86 $45.82 +137.09%
March, 2030 $14.48 $0.8518 $20.21 +48.73%
April, 2030 $26.52 $9.0606 $29.09 +172.37%
May, 2030 $27.82 $25.01 $38.00 +185.69%
June, 2030 $41.46 $27.07 $44.22 +325.87%
July, 2030 $45.64 $36.87 $46.87 +368.77%
August, 2030 $56.84 $45.38 $59.01 +483.78%
September, 2030 $60.82 $54.94 $70.39 +524.63%
October, 2030 $83.05 $58.19 $84.59 +753.02%
November, 2030 $92.19 $83.89 $121.51 +846.88%
December, 2030 $106.32 $81.31 $106.45 +991.98%
health_information_services PHR
$24.43
price down icon 0.45%
$11.29
price down icon 0.62%
$22.90
price down icon 0.09%
$22.70
price down icon 0.35%
$23.72
price down icon 0.38%
health_information_services WAY
$40.47
price up icon 1.25%
Cap:     |  Volume (24h):